Riskpilot← Back to searchSign inGet full accessAARVOLD APOTEKENE AS
ASActiveOrg 822919332Sundveien 15A, 1397 NesøyaRetail sale of pharmaceutical products · NACE 4773Est. 201920 employees
Revenue 2025
NOK 40,9M
+22% vs 2024
EBITDA margin
6.3%
+46% vs 2024
Equity ratio
2.9%
Financial strength
Net profit 2025
NOK 2M
+51% vs 2024
| Revenue | NOK 40,9M | +22% |
| EBITDA | NOK 2,6M | +46% |
| Net profit | NOK 2M | +51% |
| Total assets | NOK 8,9M | +28% |
| Equity | NOK 256K | -65% |
| Employees | 20 | — |
Legal name
AARVOLD APOTEKENE AS
Org number
822919332
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
18. juni 2019
Share capital
NOK 50 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Ordinær apotekdrift, samt salg av kompetanse og løsninger innen apotekdrift
Address
Sundveien 15A, 1397 Nesøya
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 320 | 17 446 | 24 502 | 33 559 | 40 940 |
| Staff expenses | −3 036 | −4 038 | −4 546 | −5 640 | −6 434 |
| EBITDA | −279 | 298 | 869 | 1 768 | 2 589 |
| Depreciation & amort. | −122 | −133 | −131 | −131 | −123 |
| EBIT | −401 | 165 | 738 | 1 637 | 2 466 |
| Net financials | 0 | 2 | 1 | 97 | 139 |
| Profit before tax | −400 | 167 | 739 | 1 734 | 2 605 |
| Tax | −0 | −0 | 120 | 396 | 590 |
| Net profit | −400 | 167 | 620 | 1 338 | 2 015 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 672 | 4 251 | 4 734 | 6 987 | 8 919 |
| Equity | −383 | −216 | 404 | 741 | 256 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 055 | 4 467 | 4 330 | 6 245 | 8 663 |
| Total debt | 4 055 | 4 467 | 4 330 | 6 245 | 8 663 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20212025
Equity ratio
2.9%
This company
38.2%
Market median
-92% vs market
20212025
Return on equity
786.1%
This company
18.4%
Market median
+4172% vs market
20212025
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20212025
Asset turnover
4.59×
This company
1.12×
Market median
+310% vs market
20212025
Debt / equity
33.79×
This company
0.62×
Market median
-5350% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 70% | 70% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Company | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AARVOLD APOTEKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lise Ekroll Aarvold | Board of Directors | 0 companies |
| Øystein Aarvold | Chairman | 0 companies |